Responsible for facilitating the on-time delivery of essential therapies from biopharma companies to patients, CDMOs should continue to optimize processes, enhance quality, and craft innovative strategies for client satisfaction and patient wellbeing.
In this Pharma's Almanac roundtable, David King, senior director of drug product compliance, shares his insights on how CDMOs can support the industry in addressing global health inequities.
Responsible for facilitating the on-time delivery of essential therapies from biopharma companies to patients, CDMOs should continue to optimize processes, enhance quality, and craft innovative strategies for client satisfaction and patient wellbeing.
In this Pharma's Almanac roundtable, David King, senior director of drug product compliance, shares his insights on how CDMOs can support the industry in addressing global health inequities.
- CDO
- CGMP
- ADC
- Bio Campus
- IR
- CMO
Share article